These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery. Nutescu EA, Shorr AF, Farrelly E, Horblyuk R, Happe LE, Franklin M. Ann Pharmacother; 2008 Sep; 42(9):1216-21. PubMed ID: 18611992 [Abstract] [Full Text] [Related]
4. Need to improve thromboprophylaxis across the continuum of care for surgical patients. Amin AN, Lin J, Ryan A. Adv Ther; 2010 Feb; 27(2):81-93. PubMed ID: 20390389 [Abstract] [Full Text] [Related]
5. Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis. Shorr AF, Kwong LM, Sarnes M, Happe L, Farrelly E, Mody-Patel N. Thromb Res; 2007 Feb; 121(1):17-24. PubMed ID: 17449088 [Abstract] [Full Text] [Related]
6. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation. Huse DM, Cummins G, Taylor DC, Russell MW. Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346 [Abstract] [Full Text] [Related]
9. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations. Merli G, Spyropoulos AC, Caprini JA. Ann Surg; 2009 Aug; 250(2):219-28. PubMed ID: 19638915 [Abstract] [Full Text] [Related]
11. Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial. Slavik RS, Chan E, Gorman SK, de Lemos J, Chittock D, Simons RK, Wing PC, Ho SG. J Trauma; 2007 May; 62(5):1075-81; discussion 1081. PubMed ID: 17495705 [Abstract] [Full Text] [Related]
12. Risk of thromboembolism with short-term interruption of warfarin therapy. Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othman M, Hylek EM. Arch Intern Med; 2008 Jan 14; 168(1):63-9. PubMed ID: 18195197 [Abstract] [Full Text] [Related]
16. Impact of an inpatient anticoagulation management service on clinical outcomes. Biscup-Horn PJ, Streiff MB, Ulbrich TR, Nesbit TW, Shermock KM. Ann Pharmacother; 2008 Jun 14; 42(6):777-82. PubMed ID: 18460587 [Abstract] [Full Text] [Related]
17. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study. Santamaría A, Juárez S, Reche A, Gómez-Outes A, Martínez-González J, Fontcuberta J, ESFERA Investigators. Int J Clin Pract; 2006 May 14; 60(5):518-25. PubMed ID: 16700847 [Abstract] [Full Text] [Related]
19. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation. Bui HT, Krisnaswami A, Le CU, Chan J, Shenoy BN. Am J Cardiol; 2009 Nov 15; 104(10):1429-33. PubMed ID: 19892063 [Abstract] [Full Text] [Related]